tiprankstipranks
Histogen (HSTOQ)
OTHER OTC:HSTOQ
US Market

Histogen (HSTOQ) Income Statement

Compare
648 Followers

Histogen Income Statement

Last quarter (Q3 2023), Histogen's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Histogen's net income was $-3.85M. See Histogen’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―
Gross Profit
$ 3.77M$ 699.00K$ 1.09M$ 9.24M
Operating Expenses
$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 100.00K$ 100.00K$ 100.00K$ -145.00K
EBITDA
$ -10.50M$ -14.90M$ -18.66M$ -2.86M
Operating Income
$ -10.64M$ -15.46M$ -18.86M$ -3.32M
Other Income/Expenses
$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―
Net Income
$ -10.62M$ -14.95M$ -18.77M$ -2.97M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Histogen Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis